Safety Announcement Concerning TNF Blockers
The U.S. Food and Drug Administration (FDA) is informing the public that it continues to receive reports of a rare cancer of white blood cells (known as Hepatosplenic T-Cell Lymphoma or HSTCL), primarily in adolescents and young adults being treated for Crohn’s disease and ulcerative colitis with medicines known as tumor necrosis factor (TNF) blockers, [...]
FDA Approved Biological Therapies
NEW YORK (Reuters Health) – A meta-analysis of randomized controlled trials (RCTs) supports the utilization of FDA-approved biological treatment plans in affected individuals with active Crohn’s disease or ulcerative colitis who may have been unsuccessful on the first- and second-line therapies or that happen to be depending on corticosteroids, researchers report. Lead article author Dr. [...]
lunettes: